🎯 check Ulixertinib (BVD-523) product page
Ulixertinib is a potent ERK1/2 inhibitor. It affects MAPK signaling, by blocking ERK phosphorylation, to induce apoptosis.
Ulixertinib (BVD-523): Mechanism of Action
Ulixertinib (BVD-523) MOA：Targeting ERK1/2/MAPK Pathway for Melanoma